StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q
May 26, 2017 9:52 AM
Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Medtronic, Inc. (MDT) PT Raised to $94 at BMO Capital on 4Q Beat; 'Strength Across Franchises'
May 26, 2017 10:28 AM
Medtronic (MDT): Raising PT - UBS
May 26, 2017 8:41 AM
Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight
May 26, 2017 7:59 AM
Medtronic, Inc. (MDT) PT Raised to $86 at Morgan Stanley
May 26, 2017 7:39 AM
Medtronic, Inc. (MDT) PT Raised to $95 at Cowen on 4Q Report; 'Organic Revenue Growth Trajectory Is Back on Track'
May 25, 2017 5:11 PM
Medtronic, Inc. (MDT) PT Raised to $91 at Stifel Following 4Q Report; 'Diversified Sales Growth & Robust Margins'
May 25, 2017 3:14 PM
Medtronic, Inc. (MDT) PT Raised to $91 at Evercore ISI on Strong 4Q EPS/Revenue Results; 'Gross Margin Beat Despite Mix Shift'
May 25, 2017 11:28 AM
Medtronic (MDT) Tops Q4 EPS by 2c; Sees FY18 Constant Currency Revenue Growth of 4-5%
May 25, 2017 6:46 AM
Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
May 25, 2017 6:46 AM
Medtronic (MDT) Enrolls First Patient in Study of IN.PACT AV Access Drug-Coated Balloon in Patients with ESRD
May 24, 2017 12:15 PM
Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease
May 24, 2017 12:14 PM
Medtronic (MDT) May IV bid up into Q1 EPS and outlook
May 24, 2017 10:31 AM
Mazor Robotics (MZOR): Takeout Unlikely Here - Needham
May 24, 2017 6:18 AM